---
$id: https://graph.org.ai/products/commodity/51162746
$type: Product
source: UNSPSC
code: "51162746"
title: "Tyloxapol"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tyloxapol

**UNSPSC Code**: 51162746
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a surface-active agent with the molecular formula (C15H22O(C2H4O)n)n, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y27PUL9H56, chemically known as 4-(1,1,3,3-tetramethylbutyl)phenol, polymer with formaldehyde & oxirane but more generally known as tyloxapol, which bears US NIH Compound Identifier 71388. European Medicines Agency schedules Tyloxapol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05015MIG. World Health Organization schedules tyloxapol in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TYLOXAPOL remains US FDA's Preferred Term for this commodity. Tyloxapol bears US NLM identifiers UMLS ID C0077539 and NCI Concept Code C80949. SMILES: CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1.

